Unité Mixte Internationale TransVIHMI

L’UMI 233 étudie principalement les spécificités de l’infection par le VIH au Sud et ses conséquences pour les populations. L’impact du VIH sur les autres endémies infectieuses tropicales fait que le champ des recherches aborde aussi la problématique des co-infections (hépatites, tuberculose) et d’autres maladies tropicales négligées telles que les filarioses et plus récemment l'infection par le virus Ebola. Autour de cette unité thématique, et cela depuis sa création il y a près de 20 ans, l’UMI 233 mène des travaux de recherches transversales pluridisciplinaires associant virologie, parasitologie, clinique, épidémiologie, santé publique et sciences sociales. Si le VIH et les Maladies Associées restent le thème principal de l'unité, l'unité mène des travaux sur les Maladies Tropicales Négligées comme la filariose, l'infection par le virus Ebola et tout récemment l’infection par le virus SARS-CoV-2 .
Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

21 to 30 of 71 Results
CRF.pdf
May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial
Adobe PDF - 879.3 KB - MD5: de113c80381c87ac2465ec7e903e2e56
Documentation
Case report form (PDF, 19 pages).
Data.tab
May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial
Tabular Data - 18.8 KB - 1 Variables, 546 Observations - UNF:6:QDTu5z2Y7xIeanRSu3mpUw==
Données
Main dataset, pseudoanonymized (text UTF-8, tab-separated values).
LEV-Loa-README.txt
May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial
Plain Text - 3.1 KB - MD5: 17ef164af6d4c1a6c7466501e9c45a83
Documentation
Dataset citation, dictionnary and description.
Protocole (french)
May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial
Adobe PDF - 978.7 KB - MD5: abcbc134d5a6b7e9bd11ac8cfa781362
Documentation
Study protocol (PDF, 41 pages).
Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
Mar 4, 2025
Boullé, Charlotte; Pion, Sébastien; Gardon, Jacques; Gardon-Wendel, Nathalie; Fokom Domgue, Joël; Kamgno, Joseph; Chesnais, Cédric; Boussinesq, Michel, 2025, "Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)", https://doi.org/10.23708/4GVQIJ, DataSuds, V1, UNF:6:ibS817Wds6hX+S6k9UOsdg== [fileUNF]
Data: data from two clinical trials conducted in Cameroon where L. loa MFD were determined before IVM administration. References: Gardon J, Gardon-Wendel N, Demanga-Ngangue, Kamgno J, Chippaux J-P, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with iverme...
IVM_SAE_dictionary.tab
Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
Tabular Data - 279 B - 4 Variables, 5 Observations - UNF:6:ltQ5yZeR2M0mG6wjkbhtEA==
Documentation
Data dictionary
IVM_SAE.tab
Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
Tabular Data - 259.9 KB - 6 Variables, 10506 Observations - UNF:6:tqkmhZPx/qJ/AQogYLZUNw==
Data
Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment
Loa_EIG_Data_Use_Agreement_Template.docx
Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
MS Word - 13.1 KB - MD5: db84ac6af90cc621a2d17a2ceec01e31
Documentation
A template to be filled in and signed by the data requester to access the data
ReadMe.txt
Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)
Plain Text - 3.3 KB - MD5: 816f0a76ed95e090814e677e0244a758
Documentation
Dataset citation, description and terms of use
Replication data for - Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: results from a longitudinal prospective study (the MorLo project)
Replication data for - Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: results from a longitudinal prospective study (the MorLo project)
Jan 30, 2025
Campillo, Jérémy; Pakat-Pambou, Biam-Miveck; Sahm, Bachiratou; Pion, Sebastien D. S.; Hemilembolo, Marlhand C.; Lebredonchel, Elodie; Boussinesq, Michel; Missamou, François; Chesnais, Cédric, 2025, "Replication data for - Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: results from a longitudinal prospective study (the MorLo project)", https://doi.org/10.23708/BNMZN8, DataSuds, V1, UNF:6:ot97WXQ0SsOwXC4RC0YeHw== [fileUNF]
Loiasis is endemic in Central Africa. Despite evidence of clinical complications and increased mortality, it remains excluded from the list of neglected tropical diseases. The main manifestations are Calabar swellings (CS), Eyeworm (EW) and non-specific general symptoms such arth...
Add Data

Log in to create a dataverse or add a dataset.

Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.